Chinese English Germany Japanese

Wuhan Jingkangen Biomedical Technology Co., Ltd회사는 제품 목록을 제공합니다.

회사 명:Wuhan Jingkangen Biomedical Technology Co., Ltd
전화:00-13720134139 +86 -0-15871494362
이메일:orders@jknbiochem.com
국적:China
URL: www.jknbiochem.com
총 제품 수:5224
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53

제품 카탈로그

Infliximab170277-31-3
Keliximab174722-30-6
Conatumumab896731-82-1
Erlizumab211323-03-4
Iratumumab640735-09-7
Enobosarm/MK2866841205-47-8C19H14F3N3O3
Zanolimumab652153-01-0
Citatuzumab Bogatox945228-49-9
Farletuzuma896723-44-7
Research Grade Sibrotuzumab
Tuvirumab138660-97-6
Tanezumab880266-57-9
Vosilasarm/RAD1401182367-47-0C20H16ClN5O2
Acadesine2627-69-2C9H14N4O5
Racotumomab946832-34-4
Libivirumab569658-79-3
Research Grade Anatumomab
Bapineuzumab648895-38-9
Zalutumumab667901-13-5
Galiximab357613-77-5
Raxibacumab565451-13-0
ocrelizumab637334-45-3C19H16N2O5
Canakinumab914613-48-2
Tucotuzumab Celmoleukin339986-90-2
Vapaliximab336801-86-6
Research Grade Taplitumomab
Regavirumab153101-26-9
Cardarine/GW501516317318-70-0C21H18F3NO3S2
Efungumab762260-74-2
Belimumab벨리무맙356547-88-1
Ecromeximab292819-64-8
SU540815966-93-5C18H18N2O3
Research Grade Golimumab476181-74-5
Briakinumab339308-60-0
Research Grade Bivatuzumab
reslizumab241473-69-8
Ganitumab905703-97-1
Anrukinzumab910649-32-0
Oportuzumab Monatox945228-48-8
Figitumumab943453-46-1
Stamulumab705287-60-1
Research Grade Clenoliximab182912-58-9
Catumaxomab509077-98-9
Tremelimumab745013-59-6
Elsilimomab468715-71-1
Bertilimumab375348-49-5
Ibutamoren mesylate/MK677159752-10-0C28H40N4O8S2
SR90091379686-30-2C20H24ClN3O4S
YK11431579-34-9C25H34O6
Tenatumomab1412891-40-7
Urtoxazumab502496-16-4
Cixutumumab947687-12-9
Bavituximab648904-28-3
Research Grade J695
Pagibaximab595566-61-3
Tefibazumab521079-87-8
Teneliximab395639-53-9
Metelimumab272780-74-2
Dacetuzumab880486-59-9
LGD3033917891-35-1C16H14ClF3N2O
Yttrium (90Y) Tacatuzumab Tetraxetan476413-07-7
Ertumaxomab509077-99-0
Mapatumumab658052-09-6
Volociximab558480-40-3
Ustekinumab우스테키누맙815610-63-0
Besilesomab537694-98-7
Pritumumab499212-74-7
Research Grade Priliximab147191-91-1
Maribavir176161-24-3C15H19Cl2N3O4
Tralokinumab1044515-88-9
Alacizumab934216-54-3
Ibalizumab680188-33-4
Nebacumab138661-01-5
Ipilimumab477202-00-9
Research Grade Camidanlumab921618-45-3
Otelixizumab881191-44-2
Elotuzumab915296-00-3
Panitumumab파니투무맙339177-26-3
Research Grade Pintumomab
Lexatumumab845816-02-6
Obinutuzumab아푸투주맙949142-50-1
Cetuximab세툭시맙205923-56-4C107H179N35O36S7
Andarine/S-4401900-40-1C19H18F3N3O6
Research Grade Lerdelimumab285985-06-0
Denosumab615258-40-7C6404H9912N1724O2004S50
Lemalesomab250242-54-7
Adecatumumab503605-66-1
Lumiliximab357613-86-6
Research Grade Otilimab1638332-55-4
Gantenerumab1043556-46-2
Exbivirumab569658-80-6
ofatumumab오파투무맙679818-59-8
Etaracizumab892553-42-3
notuzumab이노투주맙 오조가미신635715-01-4
Epitumomab372075-37-1
LGD40331165910-22-4C14H12F6N2O
Fresolimumab948564-73-6
Research Grade HuCC49823788-82-5
Tigatuzumab918127-53-4
Panobacumab885053-97-4
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53
Copyright 2019 © ChemicalBook. All rights reserved